MetLife, Inc. (NYSE:MET) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of MetLife, Inc. (NYSE:METGet Free Report) have been given an average recommendation of “Moderate Buy” by the thirteen research firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $79.23.

A number of research analysts have commented on MET shares. Morgan Stanley upped their price objective on MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a report on Monday, April 15th. StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research note on Friday. Piper Sandler lifted their price objective on shares of MetLife from $74.00 to $85.00 and gave the stock an “overweight” rating in a research note on Friday, April 5th. Wells Fargo & Company increased their target price on shares of MetLife from $83.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. Finally, Keefe, Bruyette & Woods lifted their price target on shares of MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a research report on Wednesday, April 10th.

Check Out Our Latest Research Report on MET

Insider Transactions at MetLife

In related news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares in the company, valued at $10,567,933.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares in the company, valued at $4,174,893.36. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Pzena Investment Management LLC lifted its holdings in shares of MetLife by 118.1% during the third quarter. Pzena Investment Management LLC now owns 10,108,992 shares of the financial services provider’s stock worth $635,957,000 after purchasing an additional 5,474,449 shares during the period. Norges Bank bought a new stake in shares of MetLife in the 4th quarter valued at about $558,460,000. Northern Trust Corp increased its stake in shares of MetLife by 3.9% in the third quarter. Northern Trust Corp now owns 7,440,583 shares of the financial services provider’s stock valued at $468,087,000 after buying an additional 276,364 shares during the period. Invesco Ltd. raised its position in shares of MetLife by 0.3% during the third quarter. Invesco Ltd. now owns 5,829,965 shares of the financial services provider’s stock worth $366,763,000 after acquiring an additional 17,375 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in shares of MetLife by 20.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,053,851 shares of the financial services provider’s stock worth $268,090,000 after acquiring an additional 700,788 shares during the period. Institutional investors own 89.81% of the company’s stock.

MetLife Price Performance

Shares of MET opened at $70.52 on Friday. The firm has a market capitalization of $50.29 billion, a PE ratio of 24.23, a PEG ratio of 0.53 and a beta of 1.03. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.16 and a quick ratio of 0.16. The company’s 50-day moving average is $71.66 and its 200-day moving average is $67.45. MetLife has a fifty-two week low of $48.95 and a fifty-two week high of $74.68.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.83. MetLife had a net margin of 3.50% and a return on equity of 20.39%. The firm had revenue of $17.02 billion during the quarter, compared to the consensus estimate of $17.73 billion. During the same period last year, the business posted $1.52 earnings per share. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. Equities analysts forecast that MetLife will post 8.71 EPS for the current year.

MetLife Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 11th. Investors of record on Tuesday, May 7th will be given a dividend of $0.545 per share. This is an increase from MetLife’s previous quarterly dividend of $0.52. This represents a $2.18 annualized dividend and a dividend yield of 3.09%. The ex-dividend date of this dividend is Monday, May 6th. MetLife’s dividend payout ratio is currently 71.48%.

MetLife declared that its Board of Directors has approved a stock buyback program on Wednesday, May 1st that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to reacquire up to 6% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its shares are undervalued.

About MetLife

(Get Free Report

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.